Form 4: H.B. Fuller Executive Reports Stock & Option Activity
Insider Trading Report
H.B. Fuller's Sr. VP of Engineering Adhesives, Joao Magalhaes, reported recent transactions involving common stock, restricted stock units, and employee stock options.
Summary
- Joao Magalhaes, Sr. VP, Engineering Adhesives for H.B. Fuller Co. (FUL), reported equity transactions on January 26, 2026.
- Acquired 149 shares of common stock at a price of $60.07 per share.
- Disposed of 71 shares of common stock at $60.07 per share, which were withheld for tax obligations.
- Beneficially owns 3,591 shares of common stock directly following these reported transactions.
- Acquired 12,647 employee stock options (Right-to-Buy) with an exercise price of $59.81. These options vest in three annual installments (33%, 33%, and 34%) beginning on January 26, 2027, and expire on January 26, 2036.
- Disposed of 149 restricted stock units (RSUs) which converted into shares of common stock on a 1-for-1 basis.
- Acquired 1,865 new restricted stock units (RSUs) which vest in three annual installments (33%, 33%, and 34%) beginning on January 26, 2027, and expire on January 26, 2029.
- Continues to beneficially own various other fully vested employee stock options with exercise prices ranging from $45.05 to $77.72, and additional restricted stock units.
Sentiment
Score: 7
Explanation: The executive acquired a significant number of new stock options and restricted stock units, indicating continued long-term incentive and alignment with company performance. While some shares were disposed of for tax purposes, this is a routine event and the overall activity suggests a positive outlook from the executive.
Positives
- Acquisition of 149 shares of common stock, increasing direct equity ownership.
- Grant of 12,647 new employee stock options, aligning executive incentives with long-term company performance.
- Grant of 1,865 new restricted stock units, further strengthening executive's vested interest in the company's future success.
Negatives
- Disposal of 71 shares of common stock to cover tax liabilities, a routine but dilutive event for direct shareholding.
Future Outlook
NA
Industry Context
This Form 4 filing details an individual executive's equity transactions and does not provide broader industry context or trends.
Stakeholder Impact
- The acquisition of new equity incentives by a senior executive aligns management's interests with those of shareholders, potentially fostering long-term value creation.
- The disposal of shares for tax purposes is a standard practice and has a minimal direct impact on other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 01/26/2018 | Date of grant for 1,658 employee stock options with an exercise price of $50.10, which are 100% vested. |
| 01/25/2019 | Date of grant for 1,681 employee stock options with an exercise price of $53.57, which are 100% vested. |
| 01/24/2020 | Date of grant for 3,021 employee stock options with an exercise price of $45.05, which are 100% vested. |
| 01/24/2021 | Date of grant for 2,850 employee stock options with an exercise price of $48.35, which are 100% vested. |
| 01/27/2022 | Date of grant for 2,952 employee stock options with an exercise price of $51.89, which are 100% vested. |
| 01/24/2023 | Date of grant for 1,882 employee stock options with an exercise price of $72.94, which are 100% vested. |
| 01/24/2024 | Date of grant for 2,231 employee stock options with an exercise price of $68.17, which are 100% vested. |
| 01/26/2025 | Date of grant for 2,627 employee stock options with an exercise price of $77.72, vesting in three annual installments beginning on this date. |
| 01/26/2026 | Transaction date for the acquisition of common stock, disposal of common stock for taxes, acquisition of new employee stock options, and acquisition/disposal of restricted stock units. |
| 01/28/2026 | Signature date of the reporting person's attorney-in-fact. |
| 02/04/2026 | Date of grant for 8,853 employee stock options with an exercise price of $61.30, vesting in three annual installments beginning on this date. Also, date of grant for 1,574.78 restricted stock units vesting in three annual installments beginning on this date. |
| 01/26/2027 | First vesting date for 12,647 employee stock options and 1,865 restricted stock units acquired on 01/26/2026. Also, expiration date for 1,658 employee stock options granted on 01/26/2018. |
| 02/04/2028 | Expiration date for 1,574.78 restricted stock units. |
| 01/25/2028 | Expiration date for 1,681 employee stock options granted on 01/25/2019. |
| 01/24/2029 | Expiration date for 3,021 employee stock options granted on 01/24/2020. |
| 01/26/2029 | Expiration date for 1,865 restricted stock units acquired on 01/26/2026. |
| 01/24/2030 | Expiration date for 2,850 employee stock options granted on 01/24/2021. |
| 01/27/2031 | Expiration date for 2,952 employee stock options granted on 01/27/2022. |
| 01/24/2032 | Expiration date for 1,882 employee stock options granted on 01/24/2023. |
| 01/24/2033 | Expiration date for 2,231 employee stock options granted on 01/24/2024. |
| 01/26/2034 | Expiration date for 2,627 employee stock options granted on 01/26/2025. |
| 02/04/2035 | Expiration date for 8,853 employee stock options granted on 02/04/2026. |
| 01/26/2036 | Expiration date for 12,647 employee stock options acquired on 01/26/2026. |
Recommendation
holdThis Form 4 filing details routine equity compensation and tax-related transactions by a senior executive. The acquisition of new stock options and restricted stock units is a positive sign of continued executive alignment with shareholder interests. However, these transactions are not indicative of a fundamental change in the company's outlook or performance that would warrant a 'buy' or 'sell' recommendation. Investors should 'hold' and monitor broader company performance and market conditions.
Keywords
H.B. Fuller, FUL, Insider Trading, Form 4, Stock Options, Restricted Stock Units, Executive Compensation, Joao Magalhaes, Equity Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.